Andreas Plückthun
Corporate Officer/Principal chez University of Zurich
Profil
Andreas Plückthun is the founder of MorphoSys AG, which was founded in 1992.
He held the title of Member-Supervisory Board from 1992 to 2007.
He is also the founder of G7 Therapeutics AG, founded in 2014.
Additionally, he is the founder of Molecular Partners AG, founded in 2004.
At Molecular Partners AG, he held the title of Non-Executive Director.
Dr. Plückthun's current job(s) include being the Director of the Biochemistry Department at the University of Zurich since 1993.
He is also a Member of the Deutsche Akademie der Technikwissenschaften eV.
In the past, Dr. Plückthun worked as a Professor at the Swiss Federal Institute of Technology.
Dr. Plückthun obtained his doctorate degree from the University of California San Diego in 1982.
Postes actifs de Andreas Plückthun
| Sociétés | Poste | Début |
|---|---|---|
| University of Zurich | Corporate Officer/Principal | 01/01/1993 |
Deutsche Akademie der Technikwissenschaften eV
 Deutsche Akademie der Technikwissenschaften eV Miscellaneous Commercial ServicesCommercial Services Deutsche Akademie der Technikwissenschaften eV advises on technical and technological issues for engineering and applied sciences. The private company is based in Munich, Germany. | Corporate Officer/Principal | - |
Anciens postes connus de Andreas Plückthun
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHOSYS AG | Fondateur | 16/05/2007 |
G7 Therapeutics AG
 G7 Therapeutics AG Pharmaceuticals: MajorHealth Technology G7 Therapeutics AG develops GPCRs for the design of novel medicine. It plays a central role in cellular responses to a diverse array of signals including neurotransmitters, hormones and metabolites, giving this class of proteins enormous pharmacological relevance. The company was founded by Lutz Kummer and Jörn Aldag and is headquartered in Schlieren, Switzerland. | Fondateur | - |
| MOLECULAR PARTNERS AG | Fondateur | - |
| Swiss Federal Institute of Technology | Corporate Officer/Principal | - |
Formation de Andreas Plückthun
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MORPHOSYS AG | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| Entreprise privées | 2 |
|---|---|
Deutsche Akademie der Technikwissenschaften eV
Deutsche Akademie der Technikwissenschaften eV Miscellaneous Commercial ServicesCommercial Services Deutsche Akademie der Technikwissenschaften eV advises on technical and technological issues for engineering and applied sciences. The private company is based in Munich, Germany. | Commercial Services |
G7 Therapeutics AG
G7 Therapeutics AG Pharmaceuticals: MajorHealth Technology G7 Therapeutics AG develops GPCRs for the design of novel medicine. It plays a central role in cellular responses to a diverse array of signals including neurotransmitters, hormones and metabolites, giving this class of proteins enormous pharmacological relevance. The company was founded by Lutz Kummer and Jörn Aldag and is headquartered in Schlieren, Switzerland. | Health Technology |
